Achievements

Patents Overview
by Status
Total
00
Granted
00
Filed
00
by Technology
Navibody
00
rBoNT
00
Virucidal Therapeutics
00
Patent List
MVRIX is building its intellectual property portfolio as both the outcome of our three platform technologies and the engine driving our business growth.
View all
Filed
KR
Nov 12, 2025
내비바디
A dual nucleic acid carrier for the selective inhibition of mutant p53 mRNA function and restoration of normal p53 function, and uses thereof
Filed
KR
Oct 21, 2025
재조합 보툴리눔 독소
FGF-BoNT fusion protein in which FGF protein and BoNT protein are fused, and a cosmetic composition comprising the same
Filed
PCT
Jul 1, 2025
내비바디
A pharmaceutical composition comprising HER2-targeting lipid nanoparticles (LNPs) encapsulating mRNA encoding the P53 protein
Filed
PCT
Jul 1, 2025
내비바디
Pharmaceutical composition of lipid nanoparticles with improved targeting ability and safety
Filed
KR
Jun 30, 2025
내비바디
Pharmaceutical composition of lipid nanoparticles with improved targeting ability and safety
Filed
KR
Jun 25, 2025
내비바디
In vivo CAR-T therapy using mRNA lipid nanoparticle (LNP) based technology for autoimmune treatment
Filed
KR
Jun 25, 2025
내비바디
An in vivo CAR-T cell therapy for lymphocytic hematological malignancies using mRNA lipid nanoparticle (LNP) technology
Filed
KR
May 11, 2025
내비바디
Lipid nanoparticles capable of simultaneously delivering antigens to cancer cells and dendritic cells, and an anti-cancer composition containing the same
Filed
KR
Mar 30, 2025
내비바디
Clusterin-fused antibody and antibody-binding lipid nanoparticles formed by the self-assembly of the antibody
Filed
PCT
Mar 6, 2025
재조합 보툴리눔 독소
Method for producing botulinum toxin using soluble partner and intein
Filed
PCT
Jan 2, 2025
살바이러스
Nanodisc comprising virus receptor and fc fragment, and antiviral use thereof
Filed
KR
Oct 24, 2024
재조합 보툴리눔 독소
FGF-BoNT fusion protein in which an FGF protein and a BoNT protein are fused, and a cosmetic composition comprising the same
Filed
KR
Oct 24, 2024
살바이러스
A pharmaceutical composition for the prevention or treatment of idiopathic pulmonary fibrosis comprising sACE2 nanodiscs
Filed
PCT
Oct 3, 2024
살바이러스
Nanodisc using dimer bonding
Filed
PCT
Oct 3, 2024
살바이러스
Nanodisc comprising angiotensin-converting enzyme 2 and fc fragment, and use thereof
Filed
CN
Aug 29, 2024
내비바디
Antibody-binding lipid nanoparticles comprising antibodies bound to membrane scaffold proteins
Filed
IN
Aug 26, 2024
내비바디
Antibody-binding lipid nanoparticle with antibody bound to membrane scaffold protein
Filed
US
Aug 20, 2024
살바이러스
Nanodisc comprising angiotensin converting enzyme 2
Filed
EU
Aug 18, 2024
내비바디
Antibody-bound lipid nanoparticle comprising antibody bound to membrane scaffold protein
Filed
JP
Jul 25, 2024
내비바디
Antibody-binding lipid nanoparticle with antibody bound to membrane scaffold protein
Filed
KR
Jul 2, 2024
내비바디
A pharmaceutical composition comprising HER2-binding lipid nanoparticles loaded with mRNA encoding the p53 protein
Filed
KR
Jun 25, 2024
살바이러스
Nanodisc containing membrane scaffold protein fused with angiotensin converting enzyme 2 and and its antiviral use therof
Filed
KR
Mar 19, 2024
살바이 러스
Nanodisc comprising angiotensin converting enzyme 2 fused with Fc fragment and use thereof
Filed
US
Mar 8, 2024
살바이러스
Viral receptor bound with sialic acid compounds
Filed
PCT
Jan 29, 2024
살바이러스
Nanodiscs comprising fab fragments and fc fragments of antibody and antiviral use thereof
Filed
US
Oct 19, 2023
살바이러스
Pharmaceutical composition for preventing or treating virus infections, comprising polymer nanodiscs
Filed
CN
Oct 13, 2023
살바이러스
Pharmaceutical composition for preventing or treating viral infections comprising polymeric nanodisks
Filed
EU
Oct 9, 2023
살바이러스
Pharmaceutical composition for preventing or treating virus infections, comprising polymer nanodiscs
Filed
PCT
Jul 4, 2023
살바이러스
Nanodisc comprising membrane scaffold protein having fc region of antibody fused thereto
Filed
PCT
Feb 9, 2023
살바이러스
Nanodisc comprising angiotensin converting enzyme 2 and antiviral use thereof
Filed
PCT
Feb 9, 2023
살바이러스
Nanodisc comprising angiotensin converting enzyme 2
Abstract
Filed
PCT
Jan 26, 2023
내비바디
Antibody-bound lipid nanoparticle comprising antibody bound to membrane scaffold protein
Filed
KR
Jul 5, 2022
살바이러스
Immunodisk for Use in Antiviral Treatment
Filed
PCT
Apr 17, 2022
살바이러스
Pharmaceutical composition for preventing or treating virus infections, comprising polymer nanodiscs
Filed
PCT
Apr 17, 2022
재조합 보툴리눔 독소
Protein complex including botulinum toxin translocation domain and endolysin and antibacterial composition including same
Filed
EU
Mar 24, 2022
살바이러스
Nano-perforator having improved anti-viral activity
Filed
US
Mar 23, 2022
살바이러스
Nano-perforator having improved anti-viral activity
Filed
IN
Mar 23, 2022
살바이러스
항-바이러스 활성이 향상된 나노 천공자
Filed
CN
Mar 22, 2022
살바이러스
Nanoperforator with enhanced antiviral activity
Filed
IN
Feb 21, 2022
재조합 보툴리눔 독소
Method for safely producing botulinum neurotoxin
Filed
KR
Jan 27, 2022
살바이러스
Antibody-conjugated lipid nanoparticle
Filed
PCT
Dec 17, 2020
재조합 보툴리눔 독소
Method for safely producing botulinum neurotoxin
Filed
PCT
Sep 21, 2020
살바이러스
Nano-perforator having improved anti-viral activity
Filed
PCT
Sep 17, 2020
살바이러스
Tag protein for increasing water solubility and heat stability of target protein, and fusion protein comprising same
12,459,978
US
Nov 4, 2025
살바이러스
Tag protein for increasing water solubility and heat stability of target protein, and fusion protein comprising same
10-2879005
KR
Oct 27, 2025
살바이러스
Nanodisc containing membrane scaffold protein fused with angiotensin converting enzyme 2 and and its antiviral use therof
12,427,204
US
Sep 30, 2025
내비바디
Antibody-bound lipid nanoparticle comprising antibody bound to membrane scaffold protein
10-2817110
KR
May 30, 2025
살바이러스
Nanodisc with antibody's Fab and Fc fragment
10-2790255
KR
Mar 28, 2025
재조합 보툴리눔 독소
Recombinant botulinum toxin and pharmaceutical compositions containing the same
12,171,814
US
Dec 24, 2024
재조합 보툴리눔 독소
Protein complex including botulinum toxin translocation domain and endolysin and antibacterial composition including same
12,171,815
US
Dec 24, 2024
재조합 보툴리눔 독소
Method for safely producing botulinum neurotoxin
10-2743941
KR
Dec 12, 2024
살바이러스
Nanodisc with virus receptor and Fc fragment and antiviral uses thereof
10-2743940
KR
Dec 12, 2024
살바이러스
Nanodisc with angiotensin converting enzyme 2 and Fc fragment and uses thereof
10-2737761
KR
Nov 28, 2024
살바이러스
Nanodisc containing membrane scaffold protein fused with Fc region of antibody and viral receptor
10-2731131
KR
Nov 12, 2024
재조합 보툴리눔 독소
Method for Producing botulinum neurotoxin using soluble partner and GP41.1 intein
10-2729353
KR
Nov 7, 2024
살바이러스
Nanodisc containing membrane scaffold protein fused with Fc region of antibody
10-2702394
KR
Aug 29, 2024
살바이러스
Nanodisc using dimer binding
10-2698524
KR
Aug 20, 2024
내비바디
Antibody-binding lipid nanoparticle with antibody bound to membrane scaffold protein
10-2695049
KR
Aug 8, 2024
살바이러스
Nanodisk with large membrane scffold protein
10-2695050
KR
Aug 8, 2024
살바이러스
Dual nanodisk with multiple nanodisks combined
ZL 202080059073.1
CN
Aug 6, 2024
재조합 보툴리눔 독소
Safe preparation of botulinum neurotoxin
10-2675750
KR
Jun 12, 2024
살바이러스
Nano-perforator having enhanced antiviral activity
11,957,697
US
Apr 16, 2024
살바이러스
Viral receptor bound with sialic acid compounds
10-2613552
KR
Dec 8, 2023
살바이러스
Tag protein for increasing solubility and thermal stability of target protein and fusion protein containing the same
10-2610178
KR
Nov 30, 2023
살바이러스
Nanodisc containing membrane scaffold protein fused with angiotensin converting enzyme 2
10-2610179
KR
Nov 30, 2023
재조합 보툴리눔 독소
A method for safe production of botulinum neurotoxin
10-2597062
KR
Oct 27, 2023
재조합 보툴리눔 독소
A method for safe production of botulinum neurotoxin using 3-part fragment production
10-2556037
KR
Jul 11, 2023
살바이러스
Pharmaceutical Composition for Preventing or Treating Viral Infection Comprising Polymer Nanodiscs
10-2547393
KR
Jun 20, 2023
재조합 보툴리눔 독소
Protein Complex Comprising Botulinum Toxin Translocation Domain and Endolysin, and Anti-Bacterial Composition Comprising Thereof
10-2540330
KR
May 31, 2023
살바이러스
Nanodisc with phosphatidylethanolamine phospholipid
10-2540331
KR
May 31, 2023
살바이러스
Polymer nanodisc with angiotensin converting enzyme 2 and its antiviral usage
11,541,100
US
Jan 3, 2023
살바이러스
Pharmaceutical composition comprising nanoperforator for preventing or treating viral infectious diseases
10-2438720
KR
Aug 26, 2022
살바이러스
Nanodisc with angiotensin converting enzyme 2 and its antiviral usage
10-2438721
KR
Aug 26, 2022
살바이러스
Nanodisc with angiotensin converting enzyme 2 and its usage for disease from angiotensin converting enzyme 2 deficiency
10-2417845
KR
Jul 1, 2022
살바이러스
A viral receptor mimic compound bound with sialic acid compounds
10-2393872
KR
Apr 28, 2022
살바이러스
Antiviral peptide from M2 protein and the use thereof
10-2181991
KR
Nov 17, 2020
살바이러스
Nano-perforator and pharmaceutical composition comprising the same for preventing or treating viral infection
10-1647178
KR
Aug 3, 2016
내비바디
Stabilized Plasmid-Lipid Particles Using polyethylen glycol-lipid composed of an Enzymatically Cleavable Linker or oligo-lysines
10-1536037
KR
Jul 6, 2015
살바이러스
Antibody-drug conjugate comprising apolipoprotein
10-1455909
KR
Oct 22, 2014
살바이러스
pH-responsive high density lipoprotein-like particle conjugate